Skip to search formSkip to main contentSkip to account menu

Elacridar

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Multidrug resistance (MDR) is a complex phenomenon caused by numerous reasons in cancer chemotherapy. It is related to the… 
2013
2013
The study objective was to develop a formulation of elacridar to overcome its dissolution-rate-limited bioavailability. Elacridar… 
Highly Cited
2012
Highly Cited
2012
The IGROVCDDP cisplatin-resistant ovarian cancer cell line is also resistant to paclitaxel and models the resistance phenotype of… 
Highly Cited
2008
Highly Cited
2008
PurposePreviously, we studied the effect of co-administration of paclitaxel with the second generation ABCB1 (p-gp) modulator… 
Highly Cited
2007
Highly Cited
2007
PurposeThe selective protein tyrosine kinase inhibitor, imatinib, inhibits the growth of glioma cells in preclinical models, but… 
Highly Cited
2004
Highly Cited
2004
Mefloquine is a chiral neurotoxic antimalarial agent showing stereoselective brain uptake in humans and rats. It is a substrate…